Melatonin attenuates the amphetamine-induced decrease in vesicular monoamine transporter-2 expression in postnatal rat striatum.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Neuroscience Letters

• Publication date

  2011-01-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.neulet.2010.11.019PMID 21078367
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Altered vesicular dopamine storage in Parkinson's disease: a premature demise.

  2008cited by this paper
• Melatonin inhibits amphetamine-induced increase in alpha-synuclein and decrease in phosphorylated tyrosine hydroxylase in SK-N-SH cells.

  2008cited by this paper
• Melatonin reduces oxidative/nitrosative stress due to drugs, toxins, metals, and herbicides.

  2008cited by this paper
• Zinc rescues dopaminergic SK-N-SH cell lines from methamphetamine-induced toxicity.

  2008cited by this paper
• The role of the plasmalemmal dopamine and vesicular monoamine transporters in methamphetamine‐induced dopaminergic deficits

  2007cited by this paper
• Dopamine affects the stability, hydration, and packing of protofibrils and fibrils of the wild type and variants of alpha-synuclein.

  2007cited by this paper
• Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid.

  2007cited by this paper
• Melatonin and its metabolites: new findings regarding their production and their radical scavenging actions.

  2007cited by this paper
• Zinc protects SK-N-SH cells from methamphetamine-induced α-synuclein expression

  2007cited by this paper
• Melatonin protects SK‐N‐SH neuroblastoma cells from amphetamine‐induced neurotoxicity

  2007cited by this paper
• Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death‐associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by α‐lipoic acid

  2007cited by this paper
• Zinc protects SK-N-SH cells from methamphetamine-induced alpha-synuclein expression.

  2007cited by this paper
• gamma-Tocopherol attenuates MPTP-induced dopamine loss more efficiently than alpha-tocopherol in mouse brain.

  2006cited by this paper
• Attenuation of Cocaine and Methamphetamine Neurotoxicity by Coenzyme Q10

  2006cited by this paper
• Parkinson’s disease: a rethink of rodent models

  2006cited by this paper
• γ-Tocopherol attenuates MPTP-induced dopamine loss more efficiently than α-tocopherol in mouse brain

  2006cited by this paper
• Cytosolic Catechols Inhibit α-Synuclein Aggregation and Facilitate the Formation of Intracellular Soluble Oligomeric Intermediates

  2006cited by this paper
• Lobeline Attenuates Methamphetamine-Induced Changes in Vesicular Monoamine Transporter 2 Immunoreactivity and Monoamine Depletions in the Striatum

  2005cited by this paper
• α-Synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells

  2005cited by this paper
• Melatonin and parkinson’s disease

  2005cited by this paper
• Reversible Inhibition of α-Synuclein Fibrillization by Dopaminochrome-mediated Conformational Alterations*

  2005cited by this paper
• A novel thiol antioxidant that crosses the blood brain barrier protects dopaminergic neurons in experimental models of Parkinson's disease

  2005cited by this paper
• The methamphetamine experience: a NIDA partnership.

  2004cited by this paper
• Could a loss of alpha-synuclein function put dopaminergic neurons at risk?

  2004cited by this paper
• Could a loss of α‐synuclein function put dopaminergic neurons at risk?

  2004cited by this paper
• Oxidative modifications of alpha-synuclein.

  2003cited by this paper
• Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress.

  2003cited by this paper
• Oxidative Modifications of α‐Synuclein

  2003cited by this paper
• Methylphenidate Alters Vesicular Monoamine Transport and Prevents Methamphetamine-Induced Dopaminergic Deficits

  2003cited by this paper
• Impact of psychostimulants on vesicular monoamine transporter function.

  2003cited by this paper
• Methamphetamine-Induced Degeneration of Dopaminergic Neurons Involves Autophagy and Upregulation of Dopamine Synthesis

  2002cited by this paper
• Melatonin attenuates MPP+‐induced neurodegeneration and glutathione impairment in the nigrostriatal dopaminergic pathway

  2002cited by this paper
• Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease.

  2002cited by this paper
• A role for alpha-synuclein in the regulation of dopamine biosynthesis.

  2002cited by this paper
• A Role for α-Synuclein in the Regulation of Dopamine Biosynthesis

  2002cited by this paper
• Is methamphetamine abuse a risk factor in parkinsonism?

  2001cited by this paper
• Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct

  2001cited by this paper
• Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.

  2000cited by this paper
• Actions of Melatonin in the Reduction of Oxidative Stress

  2000cited by this paper
• Dopamine Quinone Formation and Protein Modification Associated with the Striatal Neurotoxicity of Methamphetamine: Evidence against a Role for Extracellular Dopamine

  1999cited by this paper
• α-Synuclein Shares Physical and Functional Homology with 14-3-3 Proteins

  1999cited by this paper
• Increased Methamphetamine Neurotoxicity in Heterozygous Vesicular Monoamine Transporter 2 Knock-Out Mice

  1999cited by this paper
• alpha-Synuclein shares physical and functional homology with 14-3-3 proteins.

  1999cited by this paper
• Ultrastructural localization of the vesicular monoamine transporter 2 in mesolimbic and nigrostriatal dopaminergic neurons.

  1998cited by this paper
• Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease

  1998cited by this paper
• Melatonin‐dopamine interaction in the striatal projection area of sensorimotor cortex in the rat

  1996cited by this paper
• Estimating Hydroxyl Radical Content in Rat Brain Using Systemic and Intraventricular Salicylate: Impact of Methamphetamine

  1995cited by this paper
• Pharmacological effects of melatonin treatment on both locomotor activity and brain serotonin release in rats

  1994cited by this paper
• Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress

  1994cited by this paper
• Methamphetamine: toxicity to dopaminergic neurons.

  1985cited by this paper
• Melatonin is a potent modulator of dopamine release in the retina

  1983cited by this paper
• Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase activity

  1979cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Plausible therapeutic effects of melatonin and analogs in the dopamine-associated pathophysiology of bipolar disorder.

  2025cites this paper
• Amphetamine Exposure during Embryogenesis Alters Expression and Function of Tyrosine Hydroxylase and the Vesicular Monoamine Transporter in Adult C. elegans

  2024cites this paper
• The Common Denominators of Parkinson’s Disease Pathogenesis and Methamphetamine Abuse

  2023cites this paper
• Plant Polyphenols as Neuroprotective Agents in Parkinson's Disease Targeting Oxidative Stress.

  2020cites this paper
• Omega-3 decreases D1 and D2 receptors expression in the prefrontal cortex and prevents amphetamine-induced conditioned place preference in rats.

  2019cites this paper
• Pharmacological Effects of Melatonin as Neuroprotectant in Rodent Model: A Review on the Current Biological Evidence

  2019cites this paper
• Effect of melatonin on attenuating the isoflurane-induced oxidative damage is related to PKCα/Nrf2 signaling pathway in developing rats.

  2018cites this paper
• 3 Addictive Drugs and Synaptic Plasticity

  2018cites this paper
• Distribution characteristics of vesicular monoamine transporter in brain of mice with Parkinson disease

  2016cites this paper
• Melatonin Attenuates Methamphetamine-Induced Neurotoxicity.

  2016cites this paper
• Melatonin mediated antidepressant-like effect in the hippocampus of chronic stress-induced depression rats: Regulating vesicular monoamine transporter 2 and monoamine oxidase A levels.

  2016cites this paper
• Melatonin Protects Methamphetamine-Induced Neuroinflammation Through NF-κB and Nrf2 Pathways in Glioma Cell Line

  2015cites this paper
• Protective Effect of Melatonin on Methamphetamine-Induced Apoptosis in Glioma Cell Line

  2013cites this paper
• Addictive Drugs and Synaptic Plasticity

  2012cites this paper
• Effect of melatonin on D-amphetamine-induced neuroglial alterations in postnatal rat hippocampus and prefrontal cortex.

  2012cites this paper
• Melatonin as a Neuroprotective Agent in the Rodent Models of Parkinson’s Disease: Is it All Set to Irrefutable Clinical Translation?

  2011cites this paper